ArticleFrontiers in pharmacology2022

A KRAS-Associated Signature for Prognostic, Immune and Chemical Anti-Cancer Drug-Response Prediction in Colon Cancer.

Kangjia Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.